Bicycle Therapeutics (BCYC) Return on Sales: 2019-2025
Historic Return on Sales for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to 44.71%.
- Bicycle Therapeutics' Return on Sales rose 7207.00% to 44.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 44.71%, marking a year-over-year increase of 7207.00%. This contributed to the annual value of -145.68% for FY2024, which is 11150.00% down from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Return on Sales is 44.71%, which was up 166.54% from 16.77% recorded in Q2 2025.
- Bicycle Therapeutics' Return on Sales' 5-year high stood at 44.71% during Q3 2025, with a 5-year trough of -34.18% in Q4 2023.
- Moreover, its 3-year median value for Return on Sales was -5.31% (2023), whereas its average is -0.34%.
- As far as peak fluctuations go, Bicycle Therapeutics' Return on Sales crashed by 2,913bps in 2023, and later skyrocketed by 7,207bps in 2025.
- Over the past 5 years, Bicycle Therapeutics' Return on Sales (Quarterly) stood at -7.77% in 2021, then spiked by 272bps to -5.05% in 2022, then plummeted by 2,913bps to -34.18% in 2023, then soared by 5,622bps to 22.04% in 2024, then skyrocketed by 7,207bps to 44.71% in 2025.
- Its Return on Sales was 44.71% in Q3 2025, compared to 16.77% in Q2 2025 and 25.02% in Q1 2025.